The global market for Human Growth Hormone Drugs was valued at US$ 263 million in the year 2024 and is projected to reach a revised size of US$ 349 million by 2031, growing at a CAGR of 4.2% during the forecast period.

Human Growth Hormone Drugs Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Growth Hormone Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Growth Hormone Drugs.

The Human Growth Hormone Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Growth Hormone Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Growth Hormone Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Growth Hormone Drugs Market Report

Report Metric	Details
Report Name	Human Growth Hormone Drugs Market
Accounted market size in year	US$ 263 million
Forecasted market size in 2031	US$ 349 million
CAGR	4.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Norditropin Genotropin Humatrope Saizen Omnitrope - the Somatropin Biosimilar Somatropin Biopartners
Segment by Application	Prader-Willi Syndrome Turner Syndrome Short Stature Homeobox Gene Small for Gestational Age Chronic Renal Insufficiency Short Bowel Syndrome
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S (Denmark), Pfizer, Inc. (US), Sandoz International GmbH (Germany)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Growth Hormone Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Growth Hormone Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Human Growth Hormone Drugs Market growing?

Ans: The Human Growth Hormone Drugs Market witnessing a CAGR of 4.2% during the forecast period 2025-2031.

What is the Human Growth Hormone Drugs Market size in 2031?

Ans: The Human Growth Hormone Drugs Market size in 2031 will be US$ 349 million.

Who are the main players in the Human Growth Hormone Drugs Market report?

Ans: The main players in the Human Growth Hormone Drugs Market are Eli Lilly and Company (US), Ferring Holding SA (Switzerland), Genentech, Inc. (US), GeneScience Pharmaceuticals Co., Ltd. (China), Merck KgaA (Germany), Novo Nordisk A/S (Denmark), Pfizer, Inc. (US), Sandoz International GmbH (Germany)

What are the Application segmentation covered in the Human Growth Hormone Drugs Market report?

Ans: The Applications covered in the Human Growth Hormone Drugs Market report are Prader-Willi Syndrome, Turner Syndrome, Short Stature Homeobox Gene, Small for Gestational Age, Chronic Renal Insufficiency, Short Bowel Syndrome

What are the Type segmentation covered in the Human Growth Hormone Drugs Market report?

Ans: The Types covered in the Human Growth Hormone Drugs Market report are Norditropin, Genotropin, Humatrope, Saizen, Omnitrope - the Somatropin Biosimilar, Somatropin Biopartners

1 Human Growth Hormone Drugs Market Overview

1.1 Product Definition

1.2 Human Growth Hormone Drugs by Type

1.2.1 Global Human Growth Hormone Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Norditropin

1.2.3 Genotropin

1.2.4 Humatrope

1.2.5 Saizen

1.2.6 Omnitrope - the Somatropin Biosimilar

1.2.7 Somatropin Biopartners

1.3 Human Growth Hormone Drugs by Application

1.3.1 Global Human Growth Hormone Drugs Market Value by Application (2024 VS 2031)

1.3.2 Prader-Willi Syndrome

1.3.3 Turner Syndrome

1.3.4 Short Stature Homeobox Gene

1.3.5 Small for Gestational Age

1.3.6 Chronic Renal Insufficiency

1.3.7 Short Bowel Syndrome

1.4 Global Human Growth Hormone Drugs Market Size Estimates and Forecasts

1.4.1 Global Human Growth Hormone Drugs Revenue 2020-2031

1.4.2 Global Human Growth Hormone Drugs Sales 2020-2031

1.4.3 Global Human Growth Hormone Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Human Growth Hormone Drugs Market Competition by Manufacturers

2.1 Global Human Growth Hormone Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Human Growth Hormone Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Human Growth Hormone Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Human Growth Hormone Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Human Growth Hormone Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Human Growth Hormone Drugs, Product Type & Application

2.7 Global Key Manufacturers of Human Growth Hormone Drugs, Date of Enter into This Industry

2.8 Global Human Growth Hormone Drugs Market Competitive Situation and Trends

2.8.1 Global Human Growth Hormone Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Human Growth Hormone Drugs Players Market Share by Revenue

2.8.3 Global Human Growth Hormone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Human Growth Hormone Drugs Market Scenario by Region

3.1 Global Human Growth Hormone Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Human Growth Hormone Drugs Sales by Region: 2020-2031

3.2.1 Global Human Growth Hormone Drugs Sales by Region: 2020-2025

3.2.2 Global Human Growth Hormone Drugs Sales by Region: 2026-2031

3.3 Global Human Growth Hormone Drugs Revenue by Region: 2020-2031

3.3.1 Global Human Growth Hormone Drugs Revenue by Region: 2020-2025

3.3.2 Global Human Growth Hormone Drugs Revenue by Region: 2026-2031

3.4 North America Human Growth Hormone Drugs Market Facts & Figures by Country

3.4.1 North America Human Growth Hormone Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Human Growth Hormone Drugs Sales by Country (2020-2031)

3.4.3 North America Human Growth Hormone Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Human Growth Hormone Drugs Market Facts & Figures by Country

3.5.1 Europe Human Growth Hormone Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Human Growth Hormone Drugs Sales by Country (2020-2031)

3.5.3 Europe Human Growth Hormone Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Human Growth Hormone Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Human Growth Hormone Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Human Growth Hormone Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Human Growth Hormone Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Human Growth Hormone Drugs Market Facts & Figures by Country

3.7.1 Latin America Human Growth Hormone Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Human Growth Hormone Drugs Sales by Country (2020-2031)

3.7.3 Latin America Human Growth Hormone Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Human Growth Hormone Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Human Growth Hormone Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Human Growth Hormone Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Human Growth Hormone Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Human Growth Hormone Drugs Sales by Type (2020-2031)

4.1.1 Global Human Growth Hormone Drugs Sales by Type (2020-2025)

4.1.2 Global Human Growth Hormone Drugs Sales by Type (2026-2031)

4.1.3 Global Human Growth Hormone Drugs Sales Market Share by Type (2020-2031)

4.2 Global Human Growth Hormone Drugs Revenue by Type (2020-2031)

4.2.1 Global Human Growth Hormone Drugs Revenue by Type (2020-2025)

4.2.2 Global Human Growth Hormone Drugs Revenue by Type (2026-2031)

4.2.3 Global Human Growth Hormone Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Human Growth Hormone Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Human Growth Hormone Drugs Sales by Application (2020-2031)

5.1.1 Global Human Growth Hormone Drugs Sales by Application (2020-2025)

5.1.2 Global Human Growth Hormone Drugs Sales by Application (2026-2031)

5.1.3 Global Human Growth Hormone Drugs Sales Market Share by Application (2020-2031)

5.2 Global Human Growth Hormone Drugs Revenue by Application (2020-2031)

5.2.1 Global Human Growth Hormone Drugs Revenue by Application (2020-2025)

5.2.2 Global Human Growth Hormone Drugs Revenue by Application (2026-2031)

5.2.3 Global Human Growth Hormone Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Human Growth Hormone Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Eli Lilly and Company (US)

6.1.1 Eli Lilly and Company (US) Company Information

6.1.2 Eli Lilly and Company (US) Description and Business Overview

6.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Eli Lilly and Company (US) Human Growth Hormone Drugs Product Portfolio

6.1.5 Eli Lilly and Company (US) Recent Developments/Updates

6.2 Ferring Holding SA (Switzerland)

6.2.1 Ferring Holding SA (Switzerland) Company Information

6.2.2 Ferring Holding SA (Switzerland) Description and Business Overview

6.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Portfolio

6.2.5 Ferring Holding SA (Switzerland) Recent Developments/Updates

6.3 Genentech, Inc. (US)

6.3.1 Genentech, Inc. (US) Company Information

6.3.2 Genentech, Inc. (US) Description and Business Overview

6.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Genentech, Inc. (US) Human Growth Hormone Drugs Product Portfolio

6.3.5 Genentech, Inc. (US) Recent Developments/Updates

6.4 GeneScience Pharmaceuticals Co., Ltd. (China)

6.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Information

6.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Description and Business Overview

6.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Portfolio

6.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Developments/Updates

6.5 Merck KgaA (Germany)

6.5.1 Merck KgaA (Germany) Company Information

6.5.2 Merck KgaA (Germany) Description and Business Overview

6.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Merck KgaA (Germany) Human Growth Hormone Drugs Product Portfolio

6.5.5 Merck KgaA (Germany) Recent Developments/Updates

6.6 Novo Nordisk A/S (Denmark)

6.6.1 Novo Nordisk A/S (Denmark) Company Information

6.6.2 Novo Nordisk A/S (Denmark) Description and Business Overview

6.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Portfolio

6.6.5 Novo Nordisk A/S (Denmark) Recent Developments/Updates

6.7 Pfizer, Inc. (US)

6.7.1 Pfizer, Inc. (US) Company Information

6.7.2 Pfizer, Inc. (US) Description and Business Overview

6.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Pfizer, Inc. (US) Human Growth Hormone Drugs Product Portfolio

6.7.5 Pfizer, Inc. (US) Recent Developments/Updates

6.8 Sandoz International GmbH (Germany)

6.8.1 Sandoz International GmbH (Germany) Company Information

6.8.2 Sandoz International GmbH (Germany) Description and Business Overview

6.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Portfolio

6.8.5 Sandoz International GmbH (Germany) Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Human Growth Hormone Drugs Industry Chain Analysis

7.2 Human Growth Hormone Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Human Growth Hormone Drugs Production Mode & Process Analysis

7.4 Human Growth Hormone Drugs Sales and Marketing

7.4.1 Human Growth Hormone Drugs Sales Channels

7.4.2 Human Growth Hormone Drugs Distributors

7.5 Human Growth Hormone Drugs Customer Analysis

8 Human Growth Hormone Drugs Market Dynamics

8.1 Human Growth Hormone Drugs Industry Trends

8.2 Human Growth Hormone Drugs Market Drivers

8.3 Human Growth Hormone Drugs Market Challenges

8.4 Human Growth Hormone Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Eli Lilly and Company (US)

Ferring Holding SA (Switzerland)

Genentech, Inc. (US)

GeneScience Pharmaceuticals Co., Ltd. (China)

Merck KGaA Germany

Novo Nordisk A/S (Denmark)

Pfizer Inc. (US)

Sandoz International GmbH (Germany)

List of Tables

Table 1. Global Human Growth Hormone Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Human Growth Hormone Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Human Growth Hormone Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Human Growth Hormone Drugs Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Human Growth Hormone Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Human Growth Hormone Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Human Growth Hormone Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Human Growth Hormone Drugs Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Human Growth Hormone Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Human Growth Hormone Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Human Growth Hormone Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Human Growth Hormone Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Human Growth Hormone Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Growth Hormone Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Growth Hormone Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Human Growth Hormone Drugs Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Human Growth Hormone Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Human Growth Hormone Drugs Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Human Growth Hormone Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Human Growth Hormone Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Human Growth Hormone Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Human Growth Hormone Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Human Growth Hormone Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Human Growth Hormone Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Human Growth Hormone Drugs Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Human Growth Hormone Drugs Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Human Growth Hormone Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Human Growth Hormone Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Human Growth Hormone Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Human Growth Hormone Drugs Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Human Growth Hormone Drugs Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Human Growth Hormone Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Human Growth Hormone Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Human Growth Hormone Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Human Growth Hormone Drugs Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Human Growth Hormone Drugs Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Human Growth Hormone Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Human Growth Hormone Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Human Growth Hormone Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Human Growth Hormone Drugs Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Human Growth Hormone Drugs Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Human Growth Hormone Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Human Growth Hormone Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Human Growth Hormone Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Human Growth Hormone Drugs Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Human Growth Hormone Drugs Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Human Growth Hormone Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Human Growth Hormone Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Human Growth Hormone Drugs Sales (K Pcs) by Type (2020-2025)

Table 51. Global Human Growth Hormone Drugs Sales (K Pcs) by Type (2026-2031)

Table 52. Global Human Growth Hormone Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Human Growth Hormone Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Human Growth Hormone Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Human Growth Hormone Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Human Growth Hormone Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Human Growth Hormone Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Human Growth Hormone Drugs Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Human Growth Hormone Drugs Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Human Growth Hormone Drugs Sales (K Pcs) by Application (2020-2025)

Table 61. Global Human Growth Hormone Drugs Sales (K Pcs) by Application (2026-2031)

Table 62. Global Human Growth Hormone Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Human Growth Hormone Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Human Growth Hormone Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Human Growth Hormone Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Human Growth Hormone Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Human Growth Hormone Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Human Growth Hormone Drugs Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Human Growth Hormone Drugs Price (USD/Pcs) by Application (2026-2031)

Table 70. Eli Lilly and Company (US) Company Information

Table 71. Eli Lilly and Company (US) Description and Business Overview

Table 72. Eli Lilly and Company (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Eli Lilly and Company (US) Human Growth Hormone Drugs Product

Table 74. Eli Lilly and Company (US) Recent Developments/Updates

Table 75. Ferring Holding SA (Switzerland) Company Information

Table 76. Ferring Holding SA (Switzerland) Description and Business Overview

Table 77. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product

Table 79. Ferring Holding SA (Switzerland) Recent Developments/Updates

Table 80. Genentech, Inc. (US) Company Information

Table 81. Genentech, Inc. (US) Description and Business Overview

Table 82. Genentech, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. Genentech, Inc. (US) Human Growth Hormone Drugs Product

Table 84. Genentech, Inc. (US) Recent Developments/Updates

Table 85. GeneScience Pharmaceuticals Co., Ltd. (China) Company Information

Table 86. GeneScience Pharmaceuticals Co., Ltd. (China) Description and Business Overview

Table 87. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product

Table 89. GeneScience Pharmaceuticals Co., Ltd. (China) Recent Developments/Updates

Table 90. Merck KgaA (Germany) Company Information

Table 91. Merck KgaA (Germany) Description and Business Overview

Table 92. Merck KgaA (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Merck KgaA (Germany) Human Growth Hormone Drugs Product

Table 94. Merck KgaA (Germany) Recent Developments/Updates

Table 95. Novo Nordisk A/S (Denmark) Company Information

Table 96. Novo Nordisk A/S (Denmark) Description and Business Overview

Table 97. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product

Table 99. Novo Nordisk A/S (Denmark) Recent Developments/Updates

Table 100. Pfizer, Inc. (US) Company Information

Table 101. Pfizer, Inc. (US) Description and Business Overview

Table 102. Pfizer, Inc. (US) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. Pfizer, Inc. (US) Human Growth Hormone Drugs Product

Table 104. Pfizer, Inc. (US) Recent Developments/Updates

Table 105. Sandoz International GmbH (Germany) Company Information

Table 106. Sandoz International GmbH (Germany) Description and Business Overview

Table 107. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product

Table 109. Sandoz International GmbH (Germany) Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Human Growth Hormone Drugs Distributors List

Table 113. Human Growth Hormone Drugs Customers List

Table 114. Human Growth Hormone Drugs Market Trends

Table 115. Human Growth Hormone Drugs Market Drivers

Table 116. Human Growth Hormone Drugs Market Challenges

Table 117. Human Growth Hormone Drugs Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Human Growth Hormone Drugs

Figure 2. Global Human Growth Hormone Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Growth Hormone Drugs Market Share by Type: 2024 & 2031

Figure 4. Norditropin Product Picture

Figure 5. Genotropin Product Picture

Figure 6. Humatrope Product Picture

Figure 7. Saizen Product Picture

Figure 8. Omnitrope - the Somatropin Biosimilar Product Picture

Figure 9. Somatropin Biopartners Product Picture

Figure 10. Global Human Growth Hormone Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Human Growth Hormone Drugs Market Share by Application: 2024 & 2031

Figure 12. Prader-Willi Syndrome

Figure 13. Turner Syndrome

Figure 14. Short Stature Homeobox Gene

Figure 15. Small for Gestational Age

Figure 16. Chronic Renal Insufficiency

Figure 17. Short Bowel Syndrome

Figure 18. Global Human Growth Hormone Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Human Growth Hormone Drugs Market Size (2020-2031) & (US$ Million)

Figure 20. Global Human Growth Hormone Drugs Sales (2020-2031) & (K Pcs)

Figure 21. Global Human Growth Hormone Drugs Average Price (USD/Pcs) & (2020-2031)

Figure 22. Human Growth Hormone Drugs Report Years Considered

Figure 23. Human Growth Hormone Drugs Sales Share by Manufacturers in 2024

Figure 24. Global Human Growth Hormone Drugs Revenue Share by Manufacturers in 2024

Figure 25. Global 5 and 10 Largest Human Growth Hormone Drugs Players: Market Share by Revenue in Human Growth Hormone Drugs in 2024

Figure 26. Human Growth Hormone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 27. Global Human Growth Hormone Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 28. North America Human Growth Hormone Drugs Sales Market Share by Country (2020-2031)

Figure 29. North America Human Growth Hormone Drugs Revenue Market Share by Country (2020-2031)

Figure 30. U.S. Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Canada Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Europe Human Growth Hormone Drugs Sales Market Share by Country (2020-2031)

Figure 33. Europe Human Growth Hormone Drugs Revenue Market Share by Country (2020-2031)

Figure 34. Germany Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. France Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. U.K. Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Italy Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Russia Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Asia Pacific Human Growth Hormone Drugs Sales Market Share by Region (2020-2031)

Figure 40. Asia Pacific Human Growth Hormone Drugs Revenue Market Share by Region (2020-2031)

Figure 41. China Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Japan Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. South Korea Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. India Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Australia Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Taiwan Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Indonesia Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Thailand Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Malaysia Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Philippines Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Latin America Human Growth Hormone Drugs Sales Market Share by Country (2020-2031)

Figure 52. Latin America Human Growth Hormone Drugs Revenue Market Share by Country (2020-2031)

Figure 53. Mexico Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Brazil Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Argentina Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Middle East and Africa Human Growth Hormone Drugs Sales Market Share by Country (2020-2031)

Figure 57. Middle East and Africa Human Growth Hormone Drugs Revenue Market Share by Country (2020-2031)

Figure 58. Turkey Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Saudi Arabia Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. UAE Human Growth Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 61. Global Sales Market Share of Human Growth Hormone Drugs by Type (2020-2031)

Figure 62. Global Revenue Market Share of Human Growth Hormone Drugs by Type (2020-2031)

Figure 63. Global Human Growth Hormone Drugs Price (USD/Pcs) by Type (2020-2031)

Figure 64. Global Sales Market Share of Human Growth Hormone Drugs by Application (2020-2031)

Figure 65. Global Revenue Market Share of Human Growth Hormone Drugs by Application (2020-2031)

Figure 66. Global Human Growth Hormone Drugs Price (USD/Pcs) by Application (2020-2031)

Figure 67. Human Growth Hormone Drugs Value Chain

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions